Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis
Alexander Nikoloudis(Johannes Kepler University of Linz), Johannes Clausen(Johannes Kepler University of Linz), Olga Stiefel(Krankenhaus der Elisabethinen), Sigrid Machherndl‐Spandl(Krankenhaus der Elisabethinen), Andreas Petzer(Ordensklinikum Linz Barmherzige Schwestern), Emine Kaynak(Krankenhaus der Elisabethinen), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Robert Milanov(Krankenhaus der Elisabethinen), Michaela Binder(Durham University), Heidrun Kerschner(Krankenhaus der Elisabethinen), Irene Straßl(Krankenhaus der Elisabethinen), Michael Girschikofsky(Krankenhaus der Elisabethinen), Margarete Moyses(Krankenhaus der Elisabethinen), Dagmar Wipplinger(Krankenhaus der Elisabethinen), Stefanie Nocker(Krankenhaus der Elisabethinen), Ansgar Weltermann, Ines Julia Neumann(Johannes Kepler University of Linz), Petra Apfalter(Krankenhaus der Elisabethinen)
Cited by 10
Related Papers
Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread
|Nature Microbiology|2019|817
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|764
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
|Nature Medicine|2021|523